International Drug Companies Join BIO Ventures for Global Health to Tackle Cancer Crisis in Africa

BIO Ventures for Global Health (BVGH), is launching the African Access Initiative (AAI) at 10:30 am today at the Biotechnology Innovation Organization (BIO) International Convention at the San Diego Convention Center, Room 28AB, to address Africa’s emerging cancer crisis. Led by BVGH in partnership with Pfizer, Inc., Takeda Pharmaceutical Co., Ltd., and the African Organisation for Research and Training in Cancer (AORTIC), AAI will expand access to oncology medicines and improve cancer care in Africa. Cancer kills 60% more people in Africa than malaria, and the number of cancer deaths is expected to increase almost 70% by 2030.